(Press-News.org) Rare mutations that shut down a single gene are linked to lower cholesterol levels and a 50 percent reduction in the risk of heart attack, according to new research from Washington University School of Medicine in St. Louis, the Broad Institute at Massachusetts Institute of Technology and Harvard, and other institutions.
The gene, called NPC1L1, is of interest because it is the target of the drug ezetimibe, often prescribed to lower cholesterol.
The study appears Nov. 12 in The New England Journal of Medicine.
Everyone inherits two copies of most genes -- one copy from each parent. In the study, the researchers found that people with one inactive copy of NPC1L1 appeared to be protected against high LDL cholesterol --the so-called "bad" cholesterol -- and coronary heart disease, a narrowing of the heart's arteries that can lead to heart attacks.
"This analysis demonstrates that human genetics can guide us in terms of thinking about appropriate genes to target for clinical therapy," said first author Nathan O. Stitziel, MD, PhD, a cardiologist at Washington University School of Medicine. "When people have one copy of a gene not working, it's a little like taking a drug their entire lives that is inhibiting this gene."
The investigators mined genetic data from large clinical trials to find individuals with naturally occurring mutations in the NPC1L1 gene that completely shut it down. They analyzed multiple existing studies, pooling data from about 113,000 people. Of these trial participants, only 82 were found to have a mutation that shut off one copy of the NPC1L1 gene. No one had two inactive copies of NPC1L1. Based on a subset of data in the analysis, the researchers estimate roughly 1 in 650 people carry one inactive version of the gene.
The investigators found that people with only one working copy of the gene had LDL cholesterol levels an average of 12 milligrams per deciliter lower than the wider population of people with two working copies of the gene. This approximately 10 percent reduction in LDL cholesterol is comparable to that seen in patients taking ezetimibe. But beyond simply lowering cholesterol, the 82 people with inactive copies also had about half the risk of coronary heart disease as people with two functional copies of the gene.
The individuals with the rare gene mutations did not appear to differ from the larger population in any other ways, including in measures of blood pressure, body mass index and rates of diabetes.
"Protective mutations like the one we've just identified for heart disease are a treasure trove for understanding human biology," said senior author Sekar Kathiresan, MD, of the Broad Institute, and director of preventive cardiology at Massachusetts General Hospital. "They can teach us about the underlying causes of disease and point to important drug targets."
Among medications that lower cholesterol, ezetimibe is not in the widely prescribed class of drugs called statins, which stop the body from manufacturing its own cholesterol. Instead, ezetimibe blocks dietary cholesterol absorption in the gut by inhibiting the NPC1L1 protein, perhaps approximating the effect of having only one working copy of the NPC1L1 gene.
While ezetimibe is known for its cholesterol-lowering effect, there is debate over whether it also reduces risk of heart disease.
"It's not possible to draw a direct conclusion about ezetimibe from this study," Stitziel said. "But we can say this genetic analysis gives us some confidence that targeting this gene should reduce the risk of heart attack. Whether ezetimibe specifically is the best way to target NPC1L1 remains an open question."
Stitziel and his colleagues pointed out that this question will be addressed later this month with the reporting of results from a large clinical trial called IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT).
The trial was designed to compare outcomes -- such as cardiovascular-related death and heart attack -- in patients taking a statin plus ezetimibe versus patients taking a statin plus placebo. Together, ezetimibe plus statins have been shown to lower LDL cholesterol more than statins alone. IMPROVE-IT is expected to determine whether the combination therapy also lowers the risk of coronary heart disease beyond the benefit provided by statins alone.
INFORMATION:
This work was supported by funding from the National Heart, Lung and Blood Institute (NHLBI) and the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), grant numbers K08HL114642, T32HL007208, R01HL107816, RC2HL102926, RC2HL102925 and 5U54HG003067-11, and by a grant from the Foundation for Barnes-Jewish Hospital, a Banting Fellowship from the Canadian Institutes of Health Research, a grant from the Donovan Family Foundation, an investigator-initiated research grant from Merck, and a grant from Fondation Leducq.
Stitziel NO, et al. for the Myocardial Infarction Genetics Consortium. Inactivating mutations in NPC1L1 and protection from coronary heart disease. The New England Journal of Medicine. Nov. 12, 2014.
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient-care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
A study in which more than 43,000 children were evaluated for head trauma offers an unprecedented picture of how children most frequently suffer head injuries, report physicians at Washington University School of Medicine in St. Louis and the University of California, Davis, School of Medicine.
The findings also indicate how often such incidents result in significant brain injuries, computerized tomography (CT) scans to assess head injuries, and neurosurgery to treat them.
In children ages 12 and younger, falls were the most common cause of head injuries. In children ...
Philadelphia, PA, November 12, 2014 - Critical care is defined by life-threatening conditions, which require close evaluation, monitoring, and treatment by appropriately trained health professionals. Cardiovascular care bears these same requirements. In fact, cardiovascular disease will soon surpass even human immunodeficiency virus (HIV) as the leading cause of mortality in Sub-Saharan Africa. In the latest issue of Global Heart, researchers discuss the challenges of delivering critical care in resource-limited countries.
According to Guest Editors Vanessa Kerry, MD, ...
What time is it? The answer, no matter what your initial reference may be -- a wristwatch, a smartphone, or an alarm clock -- will always trace back to the atomic clock.
The international standard for time is set by atomic clocks -- room-sized apparatuses that keep time by measuring the natural vibration of atoms in a vacuum. The frequency of atomic vibrations determines the length of one second -- information that is beamed up to GPS satellites, which stream the data to ground receivers all over the world, synchronizing cellular and cable networks, power grids, and ...
(Santa Barbara, California) -- The world is gaining weight and becoming less healthy, and global dietary choices are harming the environment.
Those are among the findings of a paper co-authored by David Tilman, a professor in the Bren School of Environmental Science & Management, and Michael Clark, a graduate student at the University of Minnesota, where Tilman also is a professor. In "Global Diets Link Environmental Sustainability and Human Health," published today in the journal Nature, the researchers find that rising incomes and urbanization around the world are ...
MINNEAPOLIS - Taking vitamin B12 and folic acid supplements may not reduce the risk of memory and thinking problems after all, according to a new study published in the November 12, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study is one of the largest to date to test long-term use of supplements and thinking and memory skills.
The study involved people with high blood levels of homocysteine, an amino acid. High levels of homocysteine have been linked to memory loss and Alzheimer's disease.
"Since homocysteine ...
A protein that may partly explain why human brains are larger than those of other animals has been identified by scientists from two stem-cell labs at UC San Francisco, in research published in the November 13, 2014 issue of Nature.
Key experiments by the UCSF researchers revealed that the protein, called PDGFD, is made in growing brains of humans, but not in mice, and appears necessary for normal proliferation of human brain stem cells growing in a lab dish.
The scientists made their discovery as part of research in which they identified genes that are activated to ...
U.S. Army soldiers hospitalized with a psychiatric disorder have a significantly elevated suicide risk in the year following discharge from the hospital, according to research from the Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS). The yearly suicide rate for this group, 263.9 per 100,000 soldiers, was far higher than the rate of 18.5 suicides per 100,000 in the Regular Army for the same study period, the study found.
The researchers looked at data from the 12 months following a hospital discharge for more than 40,000 anonymous, Regular Army ...
It has long been known that patients recently discharged from psychiatric hospitalizations have a significantly elevated suicide risk. However, the rarity of suicide even in this high-risk segment of the population makes it impractical to justify providing intensive post-hospital suicide prevention programs to all recently discharged patients. Targeted programs for patients at especially high suicide risk would be more feasible, but it is difficult for clinicians to predict with good accuracy which patients are at high risk for suicide.
A new report published online today ...
Nearly a quarter of all patients who underwent initial breast conservation surgery (BCS) for breast cancer had a subsequent surgical intervention, according to a report published online by JAMA Surgery.
Completely removing breast cancer is seen as the best way to reduce recurrence and improve survival. A lack of consensus on an adequate margin width has led to variable rates of reexcision and, as a result, patients undergo repeat or additional surgeries, according to background information provided in the study.
Lee G. Wilke, M.D., of the University of Wisconsin School ...
A study that looked at predicting suicides in U.S. Army soldiers after they are hospitalized for a psychiatric disorder suggests that nearly 53 percent of posthospitalization suicides occurred following the 5 percent of hospitalizations with the highest predicted suicide risk, according to a report in JAMA Psychiatry.
The suicide rate in the U.S. Army has increased since 2004 and now exceeds the rate among civilians. Still, suicide is a rare outcome even among recently discharged psychiatric patients. A potentially promising approach to assess posthospitalization suicide ...
